Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
28°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
NovaBay Pharmaceuticals, Inc. Common Stock
(NY:
NBY
)
0.6100
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Mar 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NovaBay Pharmaceuticals, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
January 04, 2022
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Holds Special Meeting of Stockholders
December 21, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
DERMAdoctor’s Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance
December 13, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
November 18, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results
November 11, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition
November 08, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Closes $15.0 Million Private Placement
November 03, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement
November 01, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Earnings Perspective: Return On Capital Employed
October 01, 2021
Benzinga Pro data, NovaBay Pharmaceuticals (AMEX:NBY) reported Q2 sales of $2.13 million. Earnings fell to a loss of $1.86 million, resulting in a 22.3% decrease from last...
Via
Benzinga
NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor
September 29, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Acquires Skincare-Focused Firm For $15M
September 28, 2021
NovaBay Pharmaceuticals Inc (NYSE: NBY) has agreed to acquire DERMAdoctor LLC, a privately-held company that commercializes dermatologist-developed skincare...
Via
Benzinga
NovaBay Pharmaceuticals Signs Agreement to Acquire DERMAdoctor
September 28, 2021
From
NovaBay® Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Present at the H.C. Wainwright 23nd Annual Global Investment Conference
September 08, 2021
From
NovaBay® Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products
August 19, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports Second Quarter 2021 Financial Results
August 12, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For August 12, 2021
August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...
Via
Benzinga
NovaBay Pharmaceuticals to Hold Second Quarter 2021 Conference Call on August 12
August 05, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
21 Stocks Moving in Monday's Pre-Market Session
August 02, 2021
Gainers Exicure, Inc. (NASDAQ: XCUR) shares rose 41.5% to $1.91 in pre-market trading. Ipsen and Exicure signed an exclusive collaboration agreement to research, develop, and...
Via
Benzinga
NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
July 19, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals to Participate in Two July Investment Conferences
July 08, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Launches First of Several New Products to Expand Avenova Line
May 17, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
NovaBay Pharmaceuticals Reports First Quarter 2021 Financial Results
May 06, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
NovaBay Pharmaceuticals to Hold First Quarter 2021 Conference Call on May 6
April 29, 2021
From
NovaBay Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.